Signal763526e8

WEBINDEXED

Pfizer reported $11.2 million in federal lobbying for 2023 with focus on patent extensions and Medicare negotiation waivers under IRA implementation.

Author:congress.gov

Published:2024-02-10 00:00 UTC

Occurred:2023-12-31 00:00 UTC

Received:2026-05-31 08:00 UTC

Status Score

87%

ITG

89%

IMP

78%

NAR

53%

Analysis Insights

Topics Detected

#Lobbying Disclosures#Pharma Regulation

Entities Mentioned

@Pfizer@Congress@CMS

Technical Details

Analyst Mission

Corporate Lobbying Trackera76754d3...

Source IDN/A

Original URLhttps://lda.congress.gov

Database ID763526e8-3cbb-4802-902d-885948ffbd00

Raw Data

{
  "id": "763526e8-3cbb-4802-902d-885948ffbd00",
  "content": "Pfizer reported $11.2 million in federal lobbying for 2023 with focus on patent extensions and Medicare negotiation waivers under IRA implementation.",
  "url": "https://lda.congress.gov",
  "source_type": "web",
  "source_id": null,
  "author_id": "congress.gov",
  "published_at": "2024-02-10T00:00:00.000Z",
  "received_at": "2026-05-31T08:00:22.014Z",
  "status": "indexed",
  "relevance_score": 87,
  "case_id": null,
  "metadata": {
    "topics": [
      "Lobbying Disclosures",
      "Pharma Regulation"
    ],
    "mission": "Corporate Lobbying Tracker",
    "mentions": [
      "Pfizer",
      "Congress",
      "CMS"
    ],
    "mission_id": "a76754d3-444f-44d8-bf31-a548a575182e"
  },
  "credibility_score": 89,
  "actionability_score": 78,
  "emotional_score": 53,
  "occurred_at": "2023-12-31T00:00:00.000Z",
  "case_ids": null
}